Truist raised the firm’s price target on RadNet (RDNT) to $94 from $80 and keeps a Buy rating on the shares. The firm, which is updating its estimates to reflect Q3 earnings, raised FY24 guidance and the recently announced AI collaboration with GE Healthcare (GEHC), notes that it is raising its FY24, FY25 and FY26 adjusted EBITDA estimates for RadNet to $280.4M, $308.0M and $336.0M, respectively.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RDNT: